NCT05064189View on ClinicalTrials.gov

Protection of Corneal Epithelium Using Chitosan-N-acetylcysteine Eye Drops During and/or After Cataract Surgery

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

September 10, 2021

Study Completion Date

September 10, 2021

Conditions
Eye Diseases
Interventions
DEVICE

Lacrimera

A new preservative-free formulation of eye drops consists of a novel biopolymer, chitosan-N-acetylcysteine (C-NAC; Lacrimera®, Croma-Pharma GmbH, Leobendorf, Austria), which electrostatically binds to the mucine layer of the tear film forming a glycocalyx-like structure.

Trial Locations (1)

1140

Vienna Institute for Research in Ocular Surgery, Vienna

All Listed Sponsors
lead

Vienna Institute for Research in Ocular Surgery

OTHER